A diet enriched in docosahexanoic Acid exacerbates brain parenchymal extravasation of apo B lipoproteins induced by chronic ingestion of saturated fats

Menuka M Pallebage-Gamarallage, Virginie Lam, Ryusuke Takechi, Susan Galloway, John C L Mamo, Menuka M Pallebage-Gamarallage, Virginie Lam, Ryusuke Takechi, Susan Galloway, John C L Mamo

Abstract

Chronic ingestion of saturated fatty acids (SFAs) was previously shown to compromise blood-brain barrier integrity, leading to brain parenchymal extravasation of apolipoprotein B (apo B) lipoproteins enriched in amyloid beta. In contrast, diets enriched in mono- or polyunsaturated (PUFA) oils had no detrimental effect. Rather, n3 and n6 oils generally confer protection via suppression of inflammation. This study investigated in wild-type mice if a PUFA diet enriched in docosahexanoic acid (DHA) restored blood-brain barrier integrity and attenuated parenchymal apo B abundance induced by chronic ingestion of SFA. Cerebrovascular leakage of apo B was quantitated utilising immunofluorescent staining. The plasma concentration of brain-derived S100β was measured as a marker of cerebrovascular inflammation. In mice fed SFA for 3 months, provision thereafter of a DHA-enriched diet exacerbated parenchymal apo B retention, concomitant with a significant increase in plasma cholesterol. In contrast, provision of a low-fat diet following chronic SFA feeding had no effect on SFA-induced parenchymal apo B. The findings suggest that in a heightened state of cerebrovascular inflammation, the provision of unsaturated fatty acids may be detrimental, possibly as a consequence of a greater susceptibility for oxidation.

Figures

Figure 1
Figure 1
Three-D immunofluorescent staining of cerebral extravasation of apo B. Parenchymal leakage of apo B lipoproteins (red) is observed surrounding the cerebral microvessels. Nuclei are shown in blue. The 3D images are from mice maintained on saturated-fat diet for 5 months (SFA 5 m) and SFA fed mice randomised to LF (+LF 2 m) and DHA (+DHA 2 m) diet for further 2 months. Scale: 1 unit = 42.7 μm.
Figure 2
Figure 2
Three-dimensional (3D) quantitative analysis of apo B leakage in C57BL/6J mouse brain. Pixel intensity of apo B lipoproteins surrounding the cerebrovasculature was quantitated in 3D images from mice maintained on saturated-fat diet for 5 months (SFA 5 m) and SFA-fed mice randomised to LF (+LF 2 m) and DHA (+DHA 2 m) diet for further 2 months. The extent of apo B pixel intensity was measured in the cortex (CTX), brain stem (BS), and hippocampal formation (HPF) and expressed as per unit volume. The bars represent mean intensity and standard error of mean, where P < 0.05 considered statistically significant (* Kruskal Wallis t-test). The C57BL/6J mice randomised to DHA diet (+DHA) had elevated apo B intensities in all regions of the brain.
Figure 3
Figure 3
Effect of dietary fatty acids on plasma S100β concentration in C57BL/6J mice. The brain abundant protein S100β was measured in plasma as a surrogate marker of BBB leakage. High plasma S100β concentration in SFA-fed mice correlate with significant BBB dysfunction. In comparison to SFA 5 m group, plasma S100β was significantly increased in mice switched to the DHA diet (+DHA 2 m). The bars represent mean plasma concentration (pg/mL) and standard error of mean, where P < 0.05 considered statistically significant (* one-way ANOVA).

References

    1. Grant WB. Dietary links to Alzheimer's disease. Alzheimer's Disease Review. 1997;2:42–55.
    1. Kalmijn S, Launer LJ, Ott A, Witteman JCM, Hofman A, Breteler MMB. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Annals of Neurology. 1997;42(5):776–782.
    1. Barberger-Gateau P, Letenneur L, Deschamps V, Pérès K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. British Medical Journal. 2002;325(7370):932–933.
    1. Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer disease. Archives of Neurology. 2003;60(2):194–200.
    1. Ferrucci L, Cherubini A, Bandinelli S, et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. Journal of Clinical Endocrinology and Metabolism. 2006;91(2):439–446.
    1. Dyall SC. Amyloid-beta peptide, oxidative stress and inflammation in Alzheimer’s disease: potential neuroprotective effects of omega-3 polyunsaturated fatty acids. International Journal of Alzheimer’s Disease. 2010;2010:20 pages. Article ID 274128.
    1. Vedin I, Cederholm T, Levi YF, et al. Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. American Journal of Clinical Nutrition. 2008;87(6):1616–1622.
    1. Pastorino L, Lu KP. Pathogenic mechanisms in Alzheimer’s disease. European Journal of Pharmacology. 2006;545(1):29–38.
    1. Fukuoka A, Nakayama H, Doi K. Immunohistochemical detection of b-amyloid and β-amyloid precursor protein in the canine brain and non-neuronal epithelial tissues. Amyloid. 2004;11(3):173–178.
    1. Burns MP, Noble WJ, Olm V, et al. Co-localization of cholesterol, apolipoprotein E and fibrillar Aβ in amyloid plaques. Molecular Brain Research. 2003;110(1):119–125.
    1. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science. 1992;255(5045):728–730.
    1. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 1992;357(6378):500–503.
    1. Refolo LM, Pappolla MA, Malester B, et al. Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiology of Disease. 2000;7(4):321–331.
    1. Crossgrove JS, Li GJ, Zheng W. The choroid plexus removes β-amyloid from brain cerebrospinal fluid. Experimental Biology and Medicine. 2005;230(10):771–776.
    1. Deane R, Sagare A, Hamm K, et al. IgG-assisted age-dependent clearance of Alzheimer’s amyloid beta peptide by the blood-brain barrier neonatal Fc receptor. Journal of Neuroscience. 2005;25(50):11495–11503.
    1. Thomas T, McLendon C, Sutton ET, Thomas G. Cerebrovascular endothelial dysfunction mediated by β-amyloid. NeuroReport. 1997;8(6):1387–1391.
    1. Zlokovic B, Ghiso J, Mackic J, McComb J, Weiss M, Frangione B. Blood-brain barrier transport of circulating Alzheimer's amyloid beta. Biochemical and Biophysical Research Communications. 1993;197(3):1034–1040.
    1. Su GC, Arendash GW, Kalaria RN, Bjugstad KB, Mullan M. Intravascular infusions of soluble β-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Research. 1999;818(1):105–117.
    1. Smith SL, Andrus PK, Zhang JR, Hall ED. Direct measurement of hydroxyl radicals, lipid peroxidation, and blood- brain barrier disruption following unilateral cortical impact head injury in the rat. Journal of Neurotrauma. 1994;11(4):393–404.
    1. Galloway S, Jian L, Johnsen R, Chew S, Mamo JCL. β-Amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding. Journal of Nutritional Biochemistry. 2007;18(4):279–284.
    1. Roher AE, Esh CL, Kokjohn TA, et al. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer’s disease. Alzheimer’s and Dementia. 2009;5(1):18–29.
    1. Kuo Y, Emmerling M, Lampert H, et al. High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease. Biochemical and Biophysical Research Communications. 1999;257(3):787–791.
    1. James AP, Pal S, Gennat HC, Vine DF, Mamo JCL. The incorporation and metabolism of amyloid-β into chylomicron-like lipid emulsions. Journal of Alzheimer’s Disease. 2003;5(3):179–188.
    1. Burgess BL, McIsaac SA, Naus KE, et al. Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer’s disease mouse models with abundant Aβ in plasma. Neurobiology of Disease. 2006;24(1):114–127.
    1. Ujiie M, Dickstein DL, Carlow DA, Jefferies WA. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation. 2003;10(6):463–470.
    1. Mamo JCL, Jian L, James AP, Flicker L, Esselmann H, Wiltfang J. Plasma lipoprotein β-amyloid in subjects with Alzheimer’s disease or mild cognitive impairment. Annals of Clinical Biochemistry. 2008;45(4):395–403.
    1. Namba Y, Tsuchiya H, Ikeda K. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer’s disease. Neuroscience Letters. 1992;134(2):264–266.
    1. Takechi R, Galloway S, Pallebage-Gamarallage MMS, et al. Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid- British Journal of Nutrition. 2010;103(5):652–662.
    1. Takechi R, Galloway S, Pallebage-Gamarallage MMS, Lam V, Mamo JCL. Dietary fats, cerebrovasculature integrity and Alzheimer’s disease risk. Progress in Lipid Research. 2010;49(2):159–170.
    1. Morgan N. Fatty acids and beta-cell toxicity. Current Opinion in Clinical Nutrition and Metabolic Care. 2009;12(2):117–122.
    1. Chavali SR, Zhong WW, Forse RA. Dietary α-lenolenic acid increases TNF-α, and decreases IL-6, IL-10 in response to LPS: effects of sesamin on the A-5 desaturation of ω6 and ω3 fatty acids in mice. Prostaglandins Leukot Essent Fatty Acids. 1998;58(3):185–191.
    1. Jeffery NM, Newsholme EA, Calder PC. Level of polyunsaturated fatty acids and the n-6 to n-3 polyunsaturated fatty acid ratio in the rat diet alter serum lipid levels and lymphocyte functions. Prostaglandins Leukotrienes and Essential Fatty Acids. 1997;57(2):149–160.
    1. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis. 2003;167(2):237–242.
    1. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacological Reviews. 2005;57(2):173–185.
    1. Galloway S, Takechi R, Pallebage-Gamarallage MMS, Dhaliwal SS, Mamo JCL. Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine. Lipids in Health and Disease. 2009;8(1, article 46)
    1. Roberts CK, Barnard RJ, Liang KH, Vaziri ND. Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia. Atherosclerosis. 2002;161(1):133–141.
    1. Hayes KC, Khosla P, Hajri T, Pronczuk A. Saturated fatty acids and LDL receptor modulation in humans and monkeys. Prostaglandins Leukotrienes and Essential Fatty Acids. 1997;57(4-5):411–418.
    1. Park Y, Jones PG, Harris WS. Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids. American Journal of Clinical Nutrition. 2004;80(1):45–50.
    1. Park Y, Harris WS. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. Journal of Lipid Research. 2003;44(3):455–463.
    1. Eiselein L, Wilson DW, Lamé MW, Rutledge JC. Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. American Journal of Physiology. 2007;292(6):H2745–H2753.
    1. Maki KC, Van Elswyk ME, McCarthy D, et al. Lipid responses in mildly hypertriglyceridemic men and women to consumption of docosahexaenoic acid-enriched eggs. International Journal for Vitamin and Nutrition Research. 2003;73(5):357–368.
    1. Riediger ND, Othman R, Fitz E, Pierce GN, Suh M, Moghadasian MH. Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. European Journal of Nutrition. 2008;47(3):153–160.
    1. Calabresi L, Villa B, Canavesi M, et al. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia. Metabolismml. 2004;53(2):153–158.
    1. Almeida EA, Morales RA, Ozaki MR. Endothelial dysfunction, lipid peroxidation and cholesterol level in rabbit arteries: relationship to progressive hypercholesterolemia. Clinica e Investigacion en Arteriosclerosis. 2007;19(6):293–299.
    1. Hennig B, Toborek M, McClain CJ. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. Journal of the American College of Nutrition. 2001;20(2):97–105.
    1. Yao PM, Tabas I. Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. Journal of Biological Chemistry. 2001;276(45):42468–42476.
    1. Peng SK, Tham P, Taylor CB, Mikkelson B. Cytotoxicity of oxidation derivatives of cholesterol on cultured aortic smooth muscle cells and their effect on cholesterol biosynthesis. American Journal of Clinical Nutrition. 1979;32(5):1033–1042.
    1. Kuo YT, So PW, Parkinson JR, et al. The combined effects on neuronal activation and blood-brain barrier permeability of time and n-3 polyunsaturated fatty acids in mice, as measured in vivo using MEMRI. NeuroImage. 2010;50(4):1384–1391.
    1. Garrido A, Garate M, Campos R, Villa A, Nieto S, Valenzuela A. Increased susceptibility of cellular membranes to the induction of oxidative stress after ingestion of high doses of fish oil: effect of aging and protective action of dl-a tocopherol supplementation. Journal of Nutritional Biochemistry. 1993;4(2):118–122.
    1. Garrido A, Garrido F, Guerra R, Valenzuela A. Ingestion of high doses of fish oil increases the susceptibility of cellular membranes to the induction of oxidative stress. Lipids. 1989;24(9):833–835.
    1. Kikugawa K, Yasuhara Y, Ando K, Koyama K, Hiramoto K, Suzuki M. Effect of supplementation of n-3 polyunsaturated fatty acids on oxidative stress-induced DNA damage of rat hepatocytes. Biological and Pharmaceutical Bulletin. 2003;26(9):1239–1244.
    1. Artwohl M, Lindenmair A, Sexl V, et al. Different mechanisms of saturated versus polyunsaturated FFA-induced apoptosis in human endothelial cells. Journal of Lipid Research. 2008;49(12):2627–2640.
    1. Healy DA, Watson RWG, Newsholme P. Polyunsaturated and monounsaturated fatty acids increase neutral lipid accumulation, caspase activation and apoptosis in a neutrophil-like, differentiated hl-60 cell line. Clinical Science. 2003;104(2):171–179.

Source: PubMed

3
Abonnere